Wearable Injectors Market Trend, Share, Growth, Size and Forecast 2032

Wearable Injectors Industry Prospective:

The global Wearable Injectors market size accrued earnings worth approximately USD 7.99 Billion in 2023 and is predicted to gain revenue of about USD 19.20 Billion by 2032, is set to record a CAGR of nearly 10.24% over the period from 2024 to 2032.

The study includes drivers and restraints of the wearable injectors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the wearable injectors market on a global and regional level.

Request Free Sample

Wearable Injectors Market: Overview

Wearable injectors are drug delivery devices that are also called patch injectors or patch pumps. Drug delivery devices help to reduce the dependence on healthcare providers and lower the number of hospital visits. They also help in enhancing treatment adherence to one’s therapeutic dose regimen. Multiple injections can be avoided using wearable injectors. Wearable injectors are easy to use and offer convenience to the patients. Wearable injectors safely deliver drugs faster and are ideal for viscous, large volume drugs, which can be used for cancer, diabetes, and cardiovascular disease treatment.

The growing prevalence of chronic disorders worldwide, such as diabetes, cancer, cardiovascular diseases, etc., technological advancements in wearable injectors design, increasing investments made by major players, and favorable reimbursement policies for wearable injectors are major factors contributing to the global wearable injectors market.

Additionally, the growing preference for wearable injectors to avoid needlestick injuries caused by traditional injectors, large-scale adoption of wearable injectors, and continuous increase in the development of biologics will further propel the wearable injectors market globally. However, the high cost and availability of alternative drug delivery systems may the hamper wearable injectors market. The growing demand for biologics and monoclonal antibodies are likely to bring new growth opportunities in the wearable injectors market in the future.

In order to give the users of this report a comprehensive view of the wearable injectors market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the wearable injectors market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the wearable injectors market on a global and regional basis. 

Wearable Injectors Market: Segmentation

The study provides a decisive view of the wearable injectors market based on type, therapeutic application, end-user, and region.

By type, the market is segmented into off-body injectors and on-body injectors.

By therapeutic application, the market is segmented into cardiovascular diseases, diabetes, immuno-oncology, and others.

Home care settings, clinics, hospitals, and others form the end-user segment of the wearable injectors market.

Wearable Injectors Market: Report Scope

Wearable Injectors Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

North America dominated the global wearable injectors market with a market share of about 42% in 2018 and is estimated to maintain its leading position over the forecast time period as well. This can be attributed to the increasing prevalence of chronic diseases, such as diabetes, cancer, cardiovascular diseases etc., the presence of major market players, favorable reimbursement policies for wearable injectors, developed healthcare infrastructure, and growing adoption of wearable injectors. Europe was the second largest region in 2018 in the global wearable injectors market, due to the developed healthcare infrastructure, favorable reimbursement policies, and growing adoption of technologically advanced therapies. Asia Pacific will witness the highest CAGR over the forecast time period in the wearable injectors market globally, owing to an increasingly aging population that is prone to suffering from chronic diseases, growing health awareness, and need for self-drug administration for diabetes, cardiovascular diseases, etc.

Wearable Injectors Market: Competitive Analysis

The global wearable injectors market is led by players like:

• Medtronic PLC
• Amgen
• Ypsomed
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Becton
• Dickinson, and Company
• Valeritas, Inc.
• United Therapeutics Corporation
• SteadyMed Therapeutics
• Enable Injections
• Sensile Medical

This report segments the global wearable injectors market as follows:

Global Wearable Injectors Market: By Type

• On-Body Injectors
• Off-Body Injectors

Global Wearable Injectors Market: By Application

• Immuno-Oncology
• Diabetes
• Cardiovascular Diseases
• Others

Global Wearable Injectors Market: By End-User

• Hospitals
• Clinics
• Home Care Settings
• Others

Global Wearable Injectors Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa